- Home
- NSPR vs ALTS Comparison
NSPR vs ALTS Comparison
Compare NSPR & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- ALTS
- Stock Information
- Founded
- NSPR 2005
- ALTS 1976
- Country
- NSPR United States
- ALTS United States
- Employees
- NSPR N/A
- ALTS N/A
- Industry
- NSPR Medical/Dental Instruments
- ALTS
- Sector
- NSPR Health Care
- ALTS
- Exchange
- NSPR Nasdaq
- ALTS NYSE
- Market Cap
- NSPR 79.7M
- ALTS 103.4M
- IPO Year
- NSPR N/A
- ALTS N/A
- Fundamental
- Price
- NSPR $2.60
- ALTS $6.06
- Analyst Decision
- NSPR Strong Buy
- ALTS
- Analyst Count
- NSPR 2
- ALTS 0
- Target Price
- NSPR $4.75
- ALTS N/A
- AVG Volume (30 Days)
- NSPR 48.2K
- ALTS 146.7K
- Earning Date
- NSPR 05-09-2025
- ALTS 05-16-2025
- Dividend Yield
- NSPR N/A
- ALTS N/A
- EPS Growth
- NSPR N/A
- ALTS N/A
- EPS
- NSPR N/A
- ALTS N/A
- Revenue
- NSPR $7,009,000.00
- ALTS $12,532,000.00
- Revenue This Year
- NSPR $28.93
- ALTS N/A
- Revenue Next Year
- NSPR $172.18
- ALTS N/A
- P/E Ratio
- NSPR N/A
- ALTS N/A
- Revenue Growth
- NSPR 12.96
- ALTS N/A
- 52 Week Low
- NSPR $2.07
- ALTS $1.29
- 52 Week High
- NSPR $3.80
- ALTS $7.75
- Technical
- Relative Strength Index (RSI)
- NSPR 49.84
- ALTS 59.84
- Support Level
- NSPR $2.40
- ALTS $5.50
- Resistance Level
- NSPR $2.79
- ALTS $6.28
- Average True Range (ATR)
- NSPR 0.16
- ALTS 0.64
- MACD
- NSPR 0.01
- ALTS 0.03
- Stochastic Oscillator
- NSPR 60.42
- ALTS 47.32
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.